omniture
VIVA BIOTECH HOLDINGS / PORDA HAVAS

Latest News

Viva Biotech's Recent Conferences & Events Review

HONG KONG, May 5, 2023 /PRNewswire/ -- In April, Viva Biotech was invited to attend 2022 SAPA-China...

2023-05-05 19:58 4601

Viva Biotech Attended SAPA-China

HONG KONG, April 12, 2023 /PRNewswire/ -- 6th-7th April, the "2022 SAPA-China Annual Conference - O...

2023-04-13 11:33 2491

Latest Updates of 6 Viva's Portfolio Companies

HONG KONG, April 4, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innov...

2023-04-04 19:39 3154

Viva Biotech Announced 2022 Annual Results:

Revenue and Gross Profit with Steady Growth Competitive Advantages of One-stop Platform Continuously...

2023-03-31 00:25 4095

Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies

JERSEY CITY, N.J. and SHANGHAI, Dec. 2, 2022 /PRNewswire/ -- Focus-X Therapeutics (referred to here...

2022-12-02 18:23 4256

Portfolio Highlights: Clinical and Financial Updates of ABM, F5, AceLink, HAYA, Regenacy, and Arthrosi

SHANGHAI, Sept. 28, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnova...

2022-09-28 18:31 2089

Viva Biotech Announced 2022 Interim Results

Order Backlog Expected to Empower Future Growth with Increasing Long-term Competitive Advantages F...

2022-08-29 23:55 4012

Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis

SHANGHAI, China, July 27, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva Bio...

2022-07-27 21:30 2588
12